CliffBio
small molecule

VALSARTAN AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; VALSARTAN

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameVALSARTAN AND HYDROCHLOROTHIAZIDE
Active ingredientHYDROCHLOROTHIAZIDE; VALSARTAN
Strength12.5MG;320MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.